Skip to main content
. 2022 Nov-Dec;38(8):2266–2271. doi: 10.12669/pjms.38.8.6431

Table II.

Demographics of patients (n-23).

Item Frequency Percent
Source of admission
Acute Medical Unit (AMU) 11 47.8
COVID-19 Complex 5 21.7
Medical Departments 3 13.0
Pulmonology Department 3 13.0
Nephrology Department 1 4.3
Total 23 100.0
Presentations
Nasal Obstruction 7 30.4
N.O +Headache 8 34.8
N. O+HD +Reduced Vision 3 13.0
N. O+HD +RV+ Visual Loss 2 8.7
Cheek Swelling and ptosis 2 8.7
Lesion on Palate 1 4.3
Total 23 100.0
Co-morbidities
HTN+DM 8 34.8
HTN 5 21.7
DM 4 17.4
COPD 3 13.0
CRF 2 8.7
Malignancy 1 4.3
Total 23 100.0
COVID-19 PCR Test
COVID-19 PCR Positive 16 69.6
COVID-19 PCR Negative 7 30.4
Total 23 100.0
COVID-19 Vaccination Status
COVID -19 Vaccination yes 6 26.1
COVID -19 Vaccination No 17 73.9
Total 23 100.0
HBA1c Level
HbA1c Level 5.5% - 6.9% 4 17.4
HbA1c Level 7% - 8.9% 9 39.1
HbA1c Level 9 % - 10 % 7 30.4
HbA1c Level > 10 % 3 13.0
Total 23 100.0
Surgical procedures performed
Endoscopic removal of lesion from nose, maxillary and ethmoid sinuses Left side 9 39.1
Endoscopic removal of lesion from nose, maxillary and ethmoid sinuses Right side 6 26.1
Endoscopic clearance of lesion from orbits, pterygopalatine fossa 2 8.7
Debridement of involved Palate and Skin 1 4.3
Incision Biopsy from nasal mass 2 8.7
Full House FESS 3 13.0
Total 23 100.0

NB. NO= Nasal Obstruction, HD= Headache, RV= Reduced Vision, HTN=Hypertension,

DM = Diabetes mellitus, COPD= Chronic obstructive pulmonary disease,

CRF= Chronic renal failure FESS=Functional Endoscopic Sinus Surgery.